PATENT CLAIM ANALYSIS

Application Number: 16060250
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["544", "278000"]

Abstract:
The present invention relates to a novel dihydropyranopyrimidinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.

Claim (Index 6):
The pharmaceutical composition according to  claim 4 , wherein the tankyrase-related disease is selected from a group consisting of a cancer, multiple sclerosis (MS), a cardiovascular disease, central nervous system injury, and an inflammatory disease.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.32432
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15325651', '15325692', '14154161', '14154173', '14154170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8118690715752948
- 35 USC 102 Novelty (BERT): 0.5458911659716924
- Combined Prediction Score: 0.7852712810149346
- Mean Citation Score: 369.913976
- Max Citation Score: 422.80225
- Similarity Product: 258.89047781969606

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test